Skip to main content
Top

Clinical and Translational Oncology

Issue 7/2012

Content (11 Articles)

Editorial

SEOM clinical guidelines: a consolidated project

Juan J. Cruz Hernández, César A. Rodríguez

Clinical Guides in Oncology

SEOM clinical guidelines for myeloid growth factors

José Muñoz Langa, Pere Gascón, Javier de Castro

Clinical Guides in Oncology

Treatment of cancer pain: Spanish Society of Medical Oncology (SEOM) recommendations for clinical practice

Juan A. Virizuela, Yolanda Escobar, Javier Cassinello, Pablo Borrega

Clincal Guides in Oncology

SEOM guidelines for the treatment of bone metastases from solid tumours

Javier Cassinello Espinosa, Aránzazu González del Alba Baamonde, Fernando Rivera Herrero, Esther Holgado Martín

Clinical Guides in Oncology

SEOM guidelines for endometrial cancer

Ana Oaknin, Víctor Rodríguez-Freixinós, Isabela Díaz de Corcuera, Fernando Rivera, José María del Campo

Clinical Guides in Oncology

SEOM guidelines for cervical cancer

Ana Oaknin, Isabela Díaz de Corcuera, Víctor Rodríguez-Freixinós, Fernando Rivera, José María del Campo

Clinical Guides in Oncology

SEOM clinical guidelines for treatment of prostate cancer

José Ángel Arranz Arija, Javier Cassinello Espinosa, Miguel Ángel Climent Durán, Fernando Rivera Herrero

Clinical Guides in Oncology

SEOM clinical guidelines for the diagnosis and treatment of gastric adenocarcinoma

Fernando Rivera, Cristina Grávalos, Rocío García-Carbonero

Clinical Guides in Oncology

SEOM guidelines for gastrointestinal stromal sarcomas (GIST)

Andrés Poveda, Fernando Rivera, Javier Martín

Clinical Guides in Oncology

SEOM clinical guidelines for the management of adult soft tissue sarcomas

Xavier García del Muro Solans, Javier Martín Broto, Pilar Lianes Barragán, Ricardo Cubedo Cervera

Clinical Guides in Oncology

SEOM guideline for the treatment of malignant glioma

Alfonso Berrocal, Miguel Gil, Óscar Gallego, Carmen Balaña, Pedro Pérez Segura, Jesús García-Mata, Gaspar Reynes

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine